logo
  • STARTSIDA
  • INFORMATION OM TIES
    • INFORMATION OM TIES
    • TIES FÖR PATIENTER
    • ISO-CERTIFIERING
  • OM OSTOMYCURE
    • OM OSTOMYCURE
    • MANAGEMENT TEAM
    • PUBLIKATIONER
      • SKÖTSELMANUALER
  • FRÅGOR OCH SVAR
  • NYHETER
  • KONTAKT
    • TIES INFORMATION FORM
    • CLINICAL STUDY FORM
  • Svenska
    • Engelska
    • Tyska
    • Polska
  • STARTSIDA
  • INFORMATION OM TIES
    • INFORMATION OM TIES
    • TIES FÖR PATIENTER
    • ISO-CERTIFIERING
  • OM OSTOMYCURE
    • OM OSTOMYCURE
    • MANAGEMENT TEAM
    • PUBLIKATIONER
      • SKÖTSELMANUALER
  • FRÅGOR OCH SVAR
  • NYHETER
  • KONTAKT
    • TIES INFORMATION FORM
    • CLINICAL STUDY FORM
  • Svenska
    • Engelska
    • Tyska
    • Polska

Archives

  • Home
  •  
  • Archives
    • JANUARI 17, 2023
    • 5 COMMENTS
    OstomyCure completes important patient recruitment milestone

    OstomyCure completes important patient recruitment milestone

    20 patients have now been implanted with the TIES® device in our pivotal clinical trial OstomyCure has successfully completed a crucial patient recruitment milestone in its pivotal clinical trial of the company’s TIES implant technology. 20 patients have now been implanted with the device with participating hospitals in the UK, Sweden, Poland, Austria, and India.

    Read more
    • ostomycure
    • All,
    • Corporate,
    • TIES
    • SEPTEMBER 20, 2022
    • 20 COMMENTS
    OstomyCure continues clinical trial to fully evaluate its TIES implant

    OstomyCure continues clinical trial to fully evaluate its TIES implant

    We are delighted to announce that our clinical trial for our TIES implant has now been initiated at hospitals in the UK, Sweden, Poland, Austria and India. Read more

    • ostomycure
    • All,
    • Corporate,
    • TIES
    • JUNI 30, 2022
    • 0 COMMENTS
    Professor Manish Chand joins the OstomyCure clinical study

    Professor Manish Chand joins the OstomyCure clinical study

    Fantastic to welcome Professor Manish Chand, Consultant Colorectal Surgeon & Professor of Surgery at University College London, to the clinical evaluation of our TIES® implant

    Read more
    • ostomycure
    • All,
    • Clinical Study,
    • Patients,
    • TIES
    • MAJ 28, 2020
    • 40 COMMENTS
    Latest update on The TIES Solution

    Latest update on The TIES Solution

    In today’s Europe of stricter safety and regulatory protocols, we are committed to do whatever it takes to bring the lifestyle changing TIES solution to as many people as possible”. Read more

    • ostomycure
    • All,
    • TIES
    • MAJ 14, 2020
    • 6 COMMENTS
    New Stockholm office

    New Stockholm office

    OstomyCure has moved its Stockholm operations from Kista to the Karolinska Campus area in Solna in the heart of the bustling Stockholm life science scene.

    Read more
    • ostomycure
    • All,
    • Corporate,
    • General
    • SEPTEMBER 6, 2019
    • 10 COMMENTS
    First Patients enrolled in the C03 clinical study in the UK

    First Patients enrolled in the C03 clinical study in the UK

    Today, the first patient was enrolled in the TIES03 study of the Ostom Cure Transcuteous Implant Evacuation System (TIES®). A 64-year-old female from the UK had the TIES port successfully implanted in a procedure that took less than an hour with no complications. “We see the TIES® Solution as a potential step change for ileostomy patients, providing them with a better quality of life,” said Prof. David Jayne,

    Read more
    • ostomycure
    • All,
    • Patients,
    • TIES
    • JUNI 26, 2019
    • 0 COMMENTS
    Professor David Jayne joins the OstomyCure clinical trial

    Professor David Jayne joins the OstomyCure clinical trial

    We are pleased to announce that Professor David Jayne and his team at Leeds Teaching Hospital NHS Trust in the UK have joined our clinical trial to evaluate our TIES® implant.

    Read more
    • ostomycure
    • All,
    • Clinical Study,
    • TIES
    • FEBRUARI 20, 2019
    • 0 COMMENTS
    OstomyCure AS receives sought-after Horizon 2020 EU grant of € 2.5 Mio.

    OstomyCure AS receives sought-after Horizon 2020 EU grant of € 2.5 Mio.

    OstomyCure AS has received a EU grant of € 2.5 Mio. via the Horizon 2020 Project.(https://ec.europa.eu/programmes/horizon2020/what-horizon-2020). “This EU grant is a major milestone for OstomyCure AS, and further confirms the very unique benefits of TIES Solution which are now endorsed by a very capable public institution” – Says Dr. Ben Broennimann, CEO of OstomyCure AS

    Read more
    • ostomycure
    • All,
    • Corporate,
    • TIES
Kategorier
  • Alla
  • Clinical Study
  • Corporate
  • Okategoriserad
  • Patients
  • TIES
mest visade inlägg
  • OstomyCure AS receives sought-after Horizon 2020 EU grant of € 2.5 Mio. 11148 februari 20, 2019
  • Latest update on The TIES Solution 9463 maj 28, 2020
  • New Stockholm office 9394 maj 14, 2020
  • OstomyCure completes important patient recruitment milestone 6808 januari 17, 2023
  • First Patients enrolled in the C03 clinical study in the UK 6019 september 6, 2019
  • OstomyCure continues clinical trial to fully evaluate its TIES implant 5002 september 20, 2022
  • Professor Manish Chand joins the OstomyCure clinical study 4296 juni 30, 2022
  • Professor David Jayne joins the OstomyCure clinical trial 2194 juni 26, 2019

Photostream

    © 2025 OstomySecure. All rights reserved | Web by TR
    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits.
    Cookie settingsGOT IT
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    SPARA OCH ACCEPTERA